NR4A1 and breast carcinoma: We designated γ-secretase complex expression as a potential tool to categorize breast cancer tumors: Tumors with low γ-secretase complex expression typically lack hormone receptors and have a poor prognosis based on higher histopathological tumor grade and lower breast cancer specific survival.